Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Cost-effectiveness analysis for statin therapies in the primary prevention of coronary heart disease in Italy.

Berto P, Munro V, Gaddi A, Negrini C, Hutton J, Mast O.

Clin Drug Investig. 2000;20(2):109-21. doi: 10.2165/00044011-200020020-00006.

PMID:
23315353
[PubMed]
2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

PMID:
17408535
[PubMed - indexed for MEDLINE]
Free Article
3.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-Rubió P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
[PubMed - indexed for MEDLINE]
4.

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC.

Ann Intern Med. 2000 May 16;132(10):769-79.

PMID:
10819699
[PubMed - indexed for MEDLINE]
5.
6.

Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2007;25(12):1031-53. Review.

PMID:
18047388
[PubMed - indexed for MEDLINE]
7.
8.

A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels.

Maclaine GD, Patel H.

Int J Clin Pract. 2001 May;55(4):243-9.

PMID:
11406909
[PubMed - indexed for MEDLINE]
9.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

PMID:
11701100
[PubMed - indexed for MEDLINE]
Free Article
10.

A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.

Tárraga-López PJ, Celada-Rodríguez A, Cerdán-Oliver M, Solera-Albero J, Ocaña-López JM, López-Cara MA, De Miguel-Clave J.

Pharmacoeconomics. 2005;23(3):275-87. Erratum in: Pharmacoeconomics. 2006;24(1):106.

PMID:
15836008
[PubMed - indexed for MEDLINE]
11.

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L.

Ann Intern Med. 2009 Feb 17;150(4):243-54.

PMID:
19221376
[PubMed - indexed for MEDLINE]
12.

Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.

Coukell AJ, Wilde MI.

Pharmacoeconomics. 1998 Aug;14(2):217-36. Review.

PMID:
10186462
[PubMed - indexed for MEDLINE]
13.
14.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of statins.

Huse DM, Russell MW, Miller JD, Kraemer DF, D'Agostino RB, Ellison RC, Hartz SC.

Am J Cardiol. 1998 Dec 1;82(11):1357-63.

PMID:
9856919
[PubMed - indexed for MEDLINE]
16.

Simvastatin after orthotopic heart transplantation. Costs and consequences.

Krobot KJ, Wenke K, Reichart B.

Pharmacoeconomics. 1999 Mar;15(3):279-89.

PMID:
10537435
[PubMed - indexed for MEDLINE]
17.

Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria.

Lim SS, Vos T, Peeters A, Liew D, McNeil JJ.

Med J Aust. 2001 Nov 5;175(9):459-64.

PMID:
11758073
[PubMed - indexed for MEDLINE]
18.

Cost-effectiveness of pravastatin in secondary prevention of coronary heart disease: comparison between Belgium and the United States of a projected risk model.

Muls E, Van Ganse E, Closon MC.

Atherosclerosis. 1998 Apr;137 Suppl:S111-6.

PMID:
9694550
[PubMed - indexed for MEDLINE]
19.
20.

Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

Peura P, Martikainen J, Soini E, Hallinen T, Niskanen L.

Curr Med Res Opin. 2008 Jun;24(6):1823-32. doi: 10.1185/03007990802144705. Epub 2008 May 15.

PMID:
18485270
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk